NYSE:GSK - New York Stock Exchange, Inc. - US37733W2044 - ADR
ChartMill assigns a Buy % Consensus number of 69% to GSK. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2024-11-12 | Jefferies | Downgrade | Buy -> Hold |
2024-10-31 | Guggenheim | Downgrade | Buy -> Neutral |
2024-07-08 | UBS | Downgrade | Buy -> Neutral |
2024-07-02 | Jefferies | Maintains | Buy -> Buy |
2024-05-30 | Goldman Sachs | Initiate | Neutral |
2024-03-04 | Guggenheim | Upgrade | Neutral -> Buy |
2024-01-23 | Morgan Stanley | Initiate | Equal-Weight |
2024-01-03 | Jefferies | Upgrade | Hold -> Buy |
2022-02-11 | DZ Bank | Downgrade | Buy -> Hold |
2021-11-05 | Barclays | Upgrade | Underweight -> Equal-Weight |
2021-07-29 | Barclays | Reiterate | Underweight |
2021-07-08 | Berenberg Bank | Reiterate | Buy |
2021-07-07 | Liberum Capital | Reiterate | Reiteration |
2021-06-24 | Deutsche Bank | Upgrade | Hold |
2021-06-22 | Shore Capital | Reiterate | Hold |
2021-06-16 | Libertas Partners | Reiterate | Buy |
2021-06-14 | Berenberg Bank | Reiterate | Buy |
2021-06-11 | Deutsche Bank | Reiterate | Sell |
2021-05-19 | Deutsche Bank | Reiterate | Sell |
2021-05-10 | Berenberg Bank | Reiterate | Buy |
2021-04-21 | Shore Capital | Reiterate | Hold |
2021-04-16 | Berenberg Bank | Reiterate | Buy |
2021-04-15 | Liberum Capital | Reiterate | Buy |
2021-04-15 | Citigroup | Reiterate | Neutral |
2021-04-12 | JP Morgan Cazenove | Reiterate | Neutral |
2021-03-04 | Deutsche Bank | Reiterate | Sell |
2021-02-10 | Berenberg Bank | Reiterate | Buy |
2021-02-10 | Deutsche Bank | Reiterate | Sell |
2021-02-09 | JP Morgan Cazenove | Reiterate | Neutral |